Your trusted guide to clinical trials

Find clinical trials relevant to you, near you. Powered by AI.

Please select a valid location from the dropdown
57,547 active trials
185,907 study centers
45,494 people enrolled
noise

TrialX — your clinical trial finder

A new, easy way to participate in clinical studies.

Man doing running exercise
father and son photo
father and son photo

You are in great company.

Institutes that trust us.

New & updated studies

Browse all studies
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Natural History Study of Parathyroid Disorders

Background Parathyroid disorders are very common in the general population and include disorders of parathyroid excess, deficiency, or defects in parathyroid hormone (PTH) signaling. PTH, the main secretory product of parathyroid glands is responsible for regulation of calcium-phosphate homeostasis. Objective i) To investigate the cause of parathyroid disorders ii) To …

6 - 100 years of age Both Phase N/A
S Sami A Hasoon

Safety and Suitability of ICL for Correction of Refractive Errors Without the Use of Dispersive OVDs

The goal of this observational study is to test whether surgeries for lenses designed to be implanted in the eye to correct refractive error can be done without the need for using viscoelastic substances that are used routinely nowadays to make it easier to introduce them inside the human eye …

18 - 50 years of age Both Phase N/A
D Didem Bozak

The Analgesic Efficacy of the Ultrasound-Guided Femoral Articular Branch Block for Ambulatory Hip Arthroscopy

Hip arthroscopy surgery can be associated with significant pain. A regional anesthesia technique, the femoral articular branch block (FAB), has recently been proposed to collectively block terminal femoral and accessory obturator nerve branches to the hip joint with a single injection, theoretically blocking most of the innervation relevant to hip …

18 - 60 years of age Both Phase N/A

Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Background Bronchiolitis obliterans syndrome (BOS) is a complication people can experience after hematopoietic stem cell transplant. It usually affects people with chronic graft versus host disease (cGVHD). This occurs when donor stem cells attack the cells of the person who received them. BOS reduces airflow and oxygen levels in the …

18 - 100 years of age Both Phase 1/2
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Genomic Services Research Program

Background Genes are the instructions a person s body uses to function. Genome sequencing is a new way to look at genes that your main research team is using to learn the causes of the condition they are studying. When a new cause is found this way, it is called …

1 - 105 years of age Both Phase N/A

(VELA) Study of BLU-222 in Advanced Solid Tumors

This is a Phase 1/2, open-label, first-in-human (FIH) study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and anticancer activity of BLU-222, a selective inhibitor of CDK2.

18 - 100 years of age Both Phase 1/2

Your clinical trial journey

Find a study

Search or browse for a clinical trial near you.

Check Eligibility

Learn more about the trial and check to see if you are eligible to take part in it.

Participate

If you prequalify, connect with the study team and let your trial journey begin!

Accelerating clinical research powered by AI

Building patient connection for a better future

Family

Join us in our mission to help accelerate clinical research.

We are on a mission to make 1 billion actions made towards clinical research. ‘Actions’ are anything from searching for trials, sharing a trial, getting in touch with a study team — or something as simple as becoming a volunteer.

Become a volunteer today

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.